Ausgabe 4/2018
Inhalt (12 Artikel)
Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant Organisms
Sarah C. J. Jorgensen, Michael J. Rybak
HIV, HCV and HBV: A Review of Parallels and Differences
Maria C. Leoni, Andrew Ustianowski, Hamzah Farooq, Joop E. Arends
Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers
Kerstin J. Olbrich, Dirk Müller, Sarah Schumacher, Ekkehard Beck, Kinga Meszaros, Florian Koerber
Effect and Safety of Meropenem–Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G. Wunderink, Evangelos J. Giamarellos-Bourboulis, Galia Rahav, Amy J. Mathers, Matteo Bassetti, Jose Vazquez, Oliver A. Cornely, Joseph Solomkin, Tanaya Bhowmick, Jihad Bishara, George L. Daikos, Tim Felton, Maria Jose Lopez Furst, Eun Jeong Kwak, Francesco Menichetti, Ilana Oren, Elizabeth L. Alexander, David Griffith, Olga Lomovskaya, Jeffery Loutit, Shu Zhang, Michael N. Dudley, Keith S. Kaye
A Markov Model to Estimate Mortality Due to HIV/AIDS Using Viral Load Levels-Based States and CD4 Cell Counts: A Principal Component Analysis Approach
Claris Shoko, Delson Chikobvu, Pascal O. Bessong
Pan-Genotypic Hepatitis C Treatment with Glecaprevir and Pibrentasvir for 8 Weeks Resulted in Improved Cardiovascular and Metabolic Outcomes and Stable Renal Function: A Post-Hoc Analysis of Phase 3 Clinical Trials
Tram T. Tran, Darshan Mehta, Federico Mensa, Caroline Park, Yanjun Bao, Yuri Sanchez Gonzalez
Consider Syphilis in Case of Lymphopenia in HIV-Infected Men Who Have Sex with Men (MSM): A Single-center, Retrospective Study
Georgios Sogkas, Diana Ernst, Faranaz Atschekzei, Alexandra Jablonka, Reinhold E. Schmidt, Georg M. N. Behrens, Matthias Stoll
Development of a Risk-Scoring Tool to Determine Appropriate Level of Care in Acute Bacterial Skin and Skin Structure Infections in an Acute Healthcare Setting
Kimberly C. Claeys, Evan J. Zasowski, Abdalhamid M. Lagnf, Noor Sabagha, Donald P. Levine, Susan L. Davis, Michael J. Rybak
Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials
Gregory J. Moran, Carisa De Anda, Anita F. Das, Sinikka Green, Purvi Mehra, Philippe Prokocimer
Prevalence of Clostridium Difficile-Associated Diarrhoea in Hospitalised Patients (Results of a Russian Prospective Multicentre Study)
Natalia V. Dmitrieva, Galina A. Klyasova, Natalia V. Bakulina, Marina A. Sukhina, Sergey V. Zhuravel, Elena A. Belousova, Vladimir T. Ivashkin, Sergey V. Goryunov, Elena A. Prokhorovich, Tatyana R. Kameneva, Aleksey A. Samsonov, Andrey V. Yakovenko, Stanislav V. Kazakov
Comment on: ‘Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada’, Wilson et al., 22 June 2018
Ashleigh McGirr, Shehzad M. Iqbal, Jan Olbrecht, Lijoy Varghese
Response to McGirr et al.'s Comment on “Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada”
Michele R. Wilson, Matt Wasserman, Taj Jadavji, Maarten Postma, Marie-Claude Breton, Francois Peloquin, Stephanie R. Earnshaw, Cheryl McDade, Heather L. Sings, Raymond Farkouh